CEFTAROLINE AND CEFTOBIPROLE: REAL LIFE OFF LABEL USE IN PATIENTS WITH BJI OF THESE TWO BETALACTAMS ACTIVE AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCI Accéder au pdf ► Triffault-Fillit CValour FLaurent FGoutelle SChidiac CFerry Ton behalf of Lyon BJI Study Group Posters 39th Annual Meeting of the European Bone and Joint Infection Society 2021